-+ 0.00%
-+ 0.00%
-+ 0.00%

MINOVIA THERAPEUTICS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR MNV-201 IN MYELODYSPLASTIC SYNDROME

Reuters·10/15/2025 11:30:00

Please log in to view news